Sandeep Aggarwal1, Shrey Modi, Toney Jose. 1. Department of Surgical Disciplines, All India Institute of Medical Sciences (AIIMS), Ansari Nagar, New Delhi, 110029, India, sandeep_aiims@yahoo.co.in.
Abstract
BACKGROUND: The impact of laparoscopic sleeve gastrectomy (LSG) on various co-morbidities including type II diabetes mellitus, hypertension, and sleep apnea is well established. However, its effect on hypothyroidism has not been given due attention evidenced by the scant literature on the subject. The purpose of this report is to assess the change in thyroxine (T4) requirement in morbidly obese patients with clinical hypothyroidism after LSG. METHODS: We conducted a retrospective review of morbidly obese patients on T4 replacement therapy for clinical hypothyroidism who underwent LSG from August 2009 to July 2012 at our institution. RESULTS: Of the 200 patients who underwent LSG during this period, 21 (10.5 %) were on T4 replacement therapy preoperatively for clinical hypothyroidism. Two patients were lost to follow-up. The remaining 19 patients were categorized into two groups. Group 1 comprised 13 patients with decreased T4 requirements after LSG. Group 2 comprised six patients in whom the T4 dose remained unaltered. The mean change in T4 requirement in group 1 was 42.07 % (12-100 %). Group 1 patients had a significantly higher mean preoperative body mass index (48.7 vs. 43.0 kg/m(2); p = 0.03) than the group 2 patients. There was a significant correlation between the percentage excess weight loss and the percentage change in T4 requirement in group 1 (r = 0.607, p = 0.028). CONCLUSIONS: Sleeve gastrectomy has a favorable impact on hypothyroid status as seen by a reduction in T4 requirement in the majority of morbidly obese patients with overt hypothyroidism.
BACKGROUND: The impact of laparoscopic sleeve gastrectomy (LSG) on various co-morbidities including type II diabetes mellitus, hypertension, and sleep apnea is well established. However, its effect on hypothyroidism has not been given due attention evidenced by the scant literature on the subject. The purpose of this report is to assess the change in thyroxine (T4) requirement in morbidly obesepatients with clinical hypothyroidism after LSG. METHODS: We conducted a retrospective review of morbidly obesepatients on T4 replacement therapy for clinical hypothyroidism who underwent LSG from August 2009 to July 2012 at our institution. RESULTS: Of the 200 patients who underwent LSG during this period, 21 (10.5 %) were on T4 replacement therapy preoperatively for clinical hypothyroidism. Two patients were lost to follow-up. The remaining 19 patients were categorized into two groups. Group 1 comprised 13 patients with decreased T4 requirements after LSG. Group 2 comprised six patients in whom the T4 dose remained unaltered. The mean change in T4 requirement in group 1 was 42.07 % (12-100 %). Group 1 patients had a significantly higher mean preoperative body mass index (48.7 vs. 43.0 kg/m(2); p = 0.03) than the group 2 patients. There was a significant correlation between the percentage excess weight loss and the percentage change in T4 requirement in group 1 (r = 0.607, p = 0.028). CONCLUSIONS: Sleeve gastrectomy has a favorable impact on hypothyroid status as seen by a reduction in T4 requirement in the majority of morbidly obesepatients with overt hypothyroidism.
Authors: J H Pinkney; S J Goodrick; J Katz; A B Johnson; S L Lightman; S W Coppack; V Mohamed-Ali Journal: Clin Endocrinol (Oxf) Date: 1998-11 Impact factor: 3.478
Authors: Marina A Michalaki; Apostolos G Vagenakis; Aggeliki S Leonardou; Marianna N Argentou; Ioannis G Habeos; Maria G Makri; Agathoklis I Psyrogiannis; Fotis E Kalfarentzos; Venetsana E Kyriazopoulou Journal: Thyroid Date: 2006-01 Impact factor: 6.568
Authors: Mirjam A Lips; Hanno Pijl; Jan B van Klinken; Gerrit H de Groot; Ignace M Janssen; Bert Van Ramshorst; Bart A Van Wagensveld; Dingeman J Swank; Fracois Van Dielen; Johannes W A Smit Journal: Eur J Endocrinol Date: 2013-08-28 Impact factor: 6.664
Authors: Francisco J Ortega; José M Moreno-Navarrete; Vicent Ribas; Eduardo Esteve; Jose I Rodriguez-Hermosa; Bartomeu Ruiz; Belén Peral; Wifredo Ricart; Antonio Zorzano; José M Fernández-Real Journal: Obesity (Silver Spring) Date: 2009-04-09 Impact factor: 5.002
Authors: E Danforth; E S Horton; M O'Connell; E A Sims; A G Burger; S H Ingbar; L Braverman; A G Vagenakis Journal: J Clin Invest Date: 1979-11 Impact factor: 14.808
Authors: Helena Julià; David Benaiges; Paula Mollà; Juan Pedro-Botet; Montserrat Villatoro; Laia Fontané; Jose M Ramon; Elisenda Climent; Juana A Flores Le Roux; Alberto Goday Journal: Obes Surg Date: 2019-08 Impact factor: 4.129
Authors: Jorge Pedro; Filipe Cunha; Pedro Souteiro; João Sérgio Neves; Vanessa Guerreiro; Daniela Magalhães; Rita Bettencourt-Silva; Sofia Castro Oliveira; Maria Manuel Costa; Joana Queirós; Paula Freitas; Ana Varela; Davide Carvalho Journal: Obes Surg Date: 2018-11 Impact factor: 4.129
Authors: María Cordido; Paula Juiz-Valiña; Paula Urones; Susana Sangiao-Alvarellos; Fernando Cordido Journal: J Clin Med Date: 2022-02-28 Impact factor: 4.241